Radiopharmaceuticals

A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties.

The global radiopharmaceuticals market was worth US$3.8 billion in 2011 and is expected to be growing at a stupendous CAGR of 18.3% to reach a value of US$12.2 billion by 2018.

  • Radiopharmaceutical Usage
  • Bio-engineering in Pharmaceutical Industry
  • Engineering models in biomedicine
  • Bionic human
  • Clinical laboratory sciences
  • Biomedical data engineering

Related Conference of Radiopharmaceuticals

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
June 08-09, 2026

20th World Drug Delivery Summit

London, UK
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Radiopharmaceuticals Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in